Early Indicator Target hospitals and clinics focusing on retinal disease screening and early detection, highlighting AdaptDx Pro as a wearable, AI-assisted dark adaptometer to streamline patient throughput and improve consistency of tests.

SMB Growth Position toward smaller ophthalmology practices and independent clinics given the company's small team size and mid-tier revenue, offering scalable deployment, training, and support packages to expand adoption without heavy enterprise commitments.

AI and Consistency Emphasize AI-driven consistency in patient experience to differentiate from traditional devices, pursuing сделки with clinics seeking standardized testing protocols to reduce variability and improve diagnostic reliability.

Competitive Position Leverage parallels to mid-market medical device peers (Visionix, CENTERVUE, Heidelberg) to frame competitive benchmarks, and propose bundled solutions including software updates, analytics, and potential service tiers to win crossover customers.

Expansion Opportunities Explore partnerships with eye care networks and teleophthalmology platforms to extend reach, offering integrations with existing electronic health record systems and training resources to accelerate onboarding and usage across multiple sites.